Table 3 Population-level adherence to the intervention for resident children aged 0–260 weeks
Alternative schedule | Standard schedule | |
|---|---|---|
Ineligible 0 doses | Age <10 weeks and 0 doses | Age <10 weeks and 0 doses |
Eligible 0 doses | Age ≥10 weeks and 0 doses | Age ≥10 weeks and 0 doses |
Eligible 1 dose | Age <44 weeks and 1 dose | Age <14 weeks and 1 dose |
Eligible 2 doses | Age ≥36 weeks and 2 doses and PCV2 ≥36 weeks | Age <18 weeks and 2 doses |
Eligible 3 doses | 3 doses and age PCV3 ≥36 weeks | 3 doses and age PCV3 <36 weeks |
Eligible 4 doses | Enrolled 2 Sept 2019–7 Feb 2020 and 4 doses and age PCV4 ≥36 weeks | 4 doses and age PCV4 <36 weeks |
Incomplete | Age ≥36 weeks and 1 dose Age <36 weeks and 2 doses Age ≥36 weeks and 2 doses and age PCV2 <36 weeks | Age ≥14 weeks and 1 dose Age ≥18 weeks and 2 doses |
Cross-over | 3 doses and age PCV3 <36 weeks 4 doses and age PCV4 <36 weeks | 3 doses and age PCV3 ≥36 weeks 4 doses and age PCV4 ≥36 weeks |